Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...

Pharmacodynamic Models: Overview

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...

Quantitative Aspects of Drug-Receptor Interaction

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...

Pharmacokinetic Models: Comparison and Selection Criterion

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

High performance, large chemical coverage or both: DanishQSAR and hierarchies of post-hoc ensemble models optimized for sensitivity, specificity or balanced accuracy.

SAR and QSAR in environmental research·2025

Same author

Automated analysis of heart sound signals in screening for structural heart disease in children.

European journal of pediatrics·2024

Same author

Mercury goes Solid at room temperature at nanoscale and a potential Hg waste storage.

Scientific reports·2022

Same author

An absolute sodium abundance for a cloud-free 'hot Saturn' exoplanet.

Nature·2018

Same author

Helium in the eroding atmosphere of an exoplanet.

Nature·2018

Same author

Thermoelectric and Structural Characterization of Al-Doped ZnO/Y₂O₃ Multilayers.

Journal of nanoscience and nanotechnology·2018

Same journal

Mapping toxicity pathways of per- and polyfluoroalkyl substances using interpretable classification-based machine learning models.

SAR and QSAR in environmental research·2026

Same journal

Structure-based identification of inhibitory compounds targeting M32 metallocarboxypeptidase of <i>Leishmania donovani</i>.

SAR and QSAR in environmental research·2026

Same journal

Multiscale computational evaluation of marine fungal metabolites containing iminohydantoin-like scaffolds as anti-Alzheimer drug candidates.

SAR and QSAR in environmental research·2026

Same journal

Conformational landscapes and binding free energies of multitarget phytochemicals reveal molecular recognition mechanisms in colorectal cancer-associated proteins.

SAR and QSAR in environmental research·2026

Same journal

AI-driven QSAR modelling and virtual screening in the discovery of selective dopamine D<sub>2</sub> receptor ligands.

SAR and QSAR in environmental research·2026

Same journal

Integrating machine learning and pharmacogenomics for biomarker discovery, identification and prioritization of potential drug candidates in ovarian cancer.

SAR and QSAR in environmental research·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 22, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

QSAR models for P450 (2D6) substrate activity.

T Ringsted¹, N Nikolov, G E Jensen

¹Department of Toxicology and Risk Assessment, National Food Institute, Technical University of Denmark, DK-2860 Søborg, Denmark.

SAR and QSAR in Environmental Research

|June 23, 2009

Summary

This summary is machine-generated.

Quantitative structure-activity relationship (QSAR) models were developed to predict if chemicals are substrates for human Cytochrome P450 (CYP) 2D6 enzymes. These models can identify environmental chemicals likely metabolized by CYP 2D6.

More Related Videos

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Related Experiment Videos

Last Updated: Jun 22, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Area of Science:

Pharmacogenomics and Drug Metabolism
Computational Chemistry and Cheminformatics

Background:

Human Cytochrome P450 (CYP) enzymes are crucial for metabolizing diverse exogenous and endogenous compounds.
The CYP isoenzyme 2D6 (CYP 2D6) plays a significant role in drug and chemical metabolism.
Over 50 human CYP genes exist, highlighting the complexity of xenobiotic metabolism.

Purpose of the Study:

To construct Quantitative Structure-Activity Relationship (QSAR) models for predicting CYP 2D6 substrate activity.
To screen European Inventory of Existing Commercial Chemical Substances (EINECS) chemicals for potential CYP 2D6 metabolism.
To assess the environmental presence and biological importance of CYP 2D6 substrates.

Main Methods:

Compilation of a training dataset of 747 chemicals with in vivo human data for CYP 2D6.
Development of QSAR models using MultiCASE, Leadscope, and MDL software.
Cross-validation (leave-groups-out) of QSAR models to assess predictive performance.

Main Results:

QSAR models achieved cross-validation concordances of 71%, 81%, and 82% for substrate/non-substrate prediction.
Screening of discrete organic EINECS chemicals provided an approximate percentage of potential CYP 2D6 substrates.
Identified chemicals are potentially present in the environment, indicating exposure risks.

Conclusions:

QSAR modeling is effective for predicting CYP 2D6 substrate activity.
The developed models can help identify environmental chemicals metabolized by CYP 2D6.
Understanding CYP 2D6 substrate profiles is vital for assessing chemical safety and biological impact.